| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
225Ac-labeled girentuximab for targeted alpha therapy of CAIX-expressing renal cell cancer xenografts
|
Oosterwijk, E.
|
|
2019
|
18 |
8 |
p. e3045
|
artikel
|
| 2 |
A comparative study of exosome isolation methods for miRNA profiling in semen
|
Larriba, S.
|
|
2019
|
18 |
8 |
p. e3093
|
artikel
|
| 3 |
Activation of NFKB-JMJD3 signaling promotes bladder fibrosis via boosting bladder smooth muscle cell proliferation and collagen accumulation
|
Jianzhong, A.
|
|
2019
|
18 |
8 |
p. e3106
|
artikel
|
| 4 |
ß3-adrenoceptor inhibition of cholinergic bladder nerves requires retrograde adenosine release triggered by EPAC/PKC/ENT1 pathway in the human and rat detrusor
|
Silva, I.
|
|
2019
|
18 |
8 |
p. e3083
|
artikel
|
| 5 |
A duplex quantitative real-time PCR assay for the detection of small non-coding RNA in urinary extracellular vesicles
|
Martens-Uzunova, E.S.
|
|
2019
|
18 |
8 |
p. e3052
|
artikel
|
| 6 |
A meta-analytical approach to the molecular subtyping of prostate cancer
|
McKinney, C.
|
|
2019
|
18 |
8 |
p. e3126
|
artikel
|
| 7 |
Analysis of AR-FL and AR-V1 in whole blood of patients with castration resistant prostate cancer as a tool for predicting response to abiraterone acetate
|
Stuopelyte, K.
|
|
2019
|
18 |
8 |
p. e3107
|
artikel
|
| 8 |
Androgen receptor (AR) suppresses prostate cancer metastasis yet promotes bladder cancer metastasis via differential altering the miRNA525-5p/SLPI-mediated vasculogenic mimicry (VM) formation
|
Yang, Z.
|
|
2019
|
18 |
8 |
p. e3098
|
artikel
|
| 9 |
Androgens and TRIBs pseudokinases in modulating human prostate cells fate
|
Shologu, Z.
|
|
2019
|
18 |
8 |
p. e3134
|
artikel
|
| 10 |
A novel calcium-mediated epithelial-to-mesenchymal transition pathway controlled by lipids: an opportunity for prostate cancer adjuvant therapy
|
Bery, F.
|
|
2019
|
18 |
8 |
p. e3057
|
artikel
|
| 11 |
A novel panel of patient-derived preclinical models of prostate cancer: xenografts and PDX-derived organoids to recapitulate patients disease profiles
|
Van Hemelryk, A.
|
|
2019
|
18 |
8 |
p. e3116
|
artikel
|
| 12 |
A Phase I study of docetaxel plus synthetic lycopene in metastatic, castration-resistant and chemotherapy-naïve prostate cancer patients
|
Zi, X.
|
|
2019
|
18 |
8 |
p. e3146
|
artikel
|
| 13 |
Application of raman-spectroscopy in the diagnosis of bladder cancer in-vitro.
|
Pavlov, V.N.
|
|
2019
|
18 |
8 |
p. e3147
|
artikel
|
| 14 |
Artesunate reduces cell growth and induces ferroptosis in therapy-resistant renal cell carcinoma cells
|
Juengel, E.
|
|
2019
|
18 |
8 |
p. e3044
|
artikel
|
| 15 |
Artificial intelligence for Gleason grading in prostate cancer
|
Krzyzanowska, A.
|
|
2019
|
18 |
8 |
p. e3082
|
artikel
|
| 16 |
Assessment of prostate cancer aggressiveness using metabolomics evaluation of urine by NMR spectroscopy
|
Kdadra, M.
|
|
2019
|
18 |
8 |
p. e3111
|
artikel
|
| 17 |
A transcription factor activity profile as a prognostic signature for androgen deprivation therapy resistance predisposition in prostate cancer patients
|
Cangiano, M.
|
|
2019
|
18 |
8 |
p. e3048-e3049
|
artikel
|
| 18 |
Biomarker exploration of extracellular vesicles in renal cell carcinoma
|
Himbert, D.
|
|
2019
|
18 |
8 |
p. e3058
|
artikel
|
| 19 |
Cand1 in prostate cancer and its implication in therapy resistance to enzalutamide
|
Eigentler, A.
|
|
2019
|
18 |
8 |
p. e3145
|
artikel
|
| 20 |
Changes in the prostate in conditions of pelvic varicose (experimental study)
|
Tsukanov, A.
|
|
2019
|
18 |
8 |
p. e3087
|
artikel
|
| 21 |
Chromatin reprogramming as an adaptation mechanism in prostate cancer
|
Urbanucci, A.
|
|
2019
|
18 |
8 |
p. e3063
|
artikel
|
| 22 |
Clinical activity of vofatamab, an FGFR3 selective antibody in combination with pembrolizumab in metastatic urothelial carcinoma (mUC), updated follow up results from the interim analysis of FIERCE-22
|
Siefker-Radtke, A.
|
|
2019
|
18 |
8 |
p. e3046
|
artikel
|
| 23 |
Clinical characteristics of the stage of adenocarcionoma (ISUP) according to the results of primary prostate biopsy
|
Giyasov, Sh.I.
|
|
2019
|
18 |
8 |
p. e3119-e3120
|
artikel
|
| 24 |
Coexpression of Skp2 and Slug in advanced prostate cancer
|
Bouchal, J.
|
|
2019
|
18 |
8 |
p. e3136
|
artikel
|
| 25 |
Combined metabolite and tissue expression profiling of TOP2A and EZH2 predicts biochemical recurrence in prostate cancer radiotherapy patients
|
Hansen, A.F.
|
|
2019
|
18 |
8 |
p. e3070-e3071
|
artikel
|
| 26 |
Combined targeting of cholesterol and steroid biosynthesis effectively inhibits enzalutamide resistant prostate cancer cells and 3-dimensional spheroid growth
|
Neuwirt, H.N.
|
|
2019
|
18 |
8 |
p. e3099
|
artikel
|
| 27 |
Comprehensive multi-omic profiling of tumor endothelial cells of prostate tissue
|
Pircher, A.
|
|
2019
|
18 |
8 |
p. e3061
|
artikel
|
| 28 |
Contribution of pseudokinase TRIB1 to prostate cancer biology
|
Shahrouzi, P.
|
|
2019
|
18 |
8 |
p. e3133
|
artikel
|
| 29 |
Cross-resistance to Cabozantinib in renal cell carcinoma second-line treatment?
|
Zaccagnino, A.
|
|
2019
|
18 |
8 |
p. e3105
|
artikel
|
| 30 |
Cytoreductive primary tumor removal slows down disease progression in an orthotopic xenograft model of prostate cancer
|
Linxweiler, J.
|
|
2019
|
18 |
8 |
p. e3050
|
artikel
|
| 31 |
Cytotoxic and apoptotic effects of new CYP17A1 inhibitor in prostate cancer cell lines
|
Pokrovsky, V.S.
|
|
2019
|
18 |
8 |
p. e3103
|
artikel
|
| 32 |
Detectable biomarkers in urine for prostate cancer prognosis
|
Krossa, S.
|
|
2019
|
18 |
8 |
p. e3084
|
artikel
|
| 33 |
Detecting clinically significant prostate cancer with urine: A multivariable risk model integrating urinary proteomic and cell-free RNA data
|
Connell, S.P.
|
|
2019
|
18 |
8 |
p. e3150
|
artikel
|
| 34 |
Development and histological components of the prostate in human fetuses
|
Julio Junior, H.
|
|
2019
|
18 |
8 |
p. e3067
|
artikel
|
| 35 |
DNA methylation biomarkers of clear cell renal carcinoma
|
Jarmalaite, S.
|
|
2019
|
18 |
8 |
p. e3088
|
artikel
|
| 36 |
Docetaxel efficacy in prostate cancer is affected by testosterone; unraveling clinical observations
|
Mout, L.
|
|
2019
|
18 |
8 |
p. e3125
|
artikel
|
| 37 |
Downregulation of BRCA1 and CTCF in clear cell renal cell carcinoma
|
Siedlecki, J.A.
|
|
2019
|
18 |
8 |
p. e3113
|
artikel
|
| 38 |
Drivers and therapeutic vulnerabilities in AR indifferent anti-androgen resistant prostate cancer cells
|
Handle, F.
|
|
2019
|
18 |
8 |
p. e3104
|
artikel
|
| 39 |
Editorial Board
|
|
|
2019
|
18 |
8 |
p. i-ii
|
artikel
|
| 40 |
Effects of systemic glucocorticoid administration on stromal and epithelial GR signaling with consequences for prostate cancer progression.
|
Puhr, M.
|
|
2019
|
18 |
8 |
p. e3062
|
artikel
|
| 41 |
Enhanced radiosensitization by apalutamide via suppression of DNA damage response in prostate cancer
|
Zhang, W.
|
|
2019
|
18 |
8 |
p. e3077
|
artikel
|
| 42 |
Epigenetic reprogramming and mitochondrial dynamics drive self-renewal and tumorigenic capability of prostate cancer stem cells: new prospects for treatment of prostate cancer
|
Civenni, G.
|
|
2019
|
18 |
8 |
p. e3109
|
artikel
|
| 43 |
“EpiProState”: Prostate cancer detection by DNA methylation assessment in liquid biopsies
|
Constâncio, V.
|
|
2019
|
18 |
8 |
p. e3110
|
artikel
|
| 44 |
ERH promotes bladder cancer cells proliferation and tumorigenesis regulating the PERK/ eIF2α Pathway by combining protein eIF2α
|
Pang, K.
|
|
2019
|
18 |
8 |
p. e3096
|
artikel
|
| 45 |
Evaluating multicellular contributions to the maintenance of AR activity under conditions of androgen deprivation
|
Umbreen, S.
|
|
2019
|
18 |
8 |
p. e3137
|
artikel
|
| 46 |
Expression fingerprint of total seminal plasma micror.n.a.s as potential non-invasive biomarker test for diagnosis and prognosis of prostate cancer
|
Larriba, S.
|
|
2019
|
18 |
8 |
p. e3069
|
artikel
|
| 47 |
Expression of DKK1 and LRP5 in renal cell carcinoma bone metastasis
|
Huang, Z.
|
|
2019
|
18 |
8 |
p. e3117
|
artikel
|
| 48 |
Expression of stromal elements of prostatic adenocarcinomas in the different Gleason scores
|
Osorio, C.F.
|
|
2019
|
18 |
8 |
p. e3065
|
artikel
|
| 49 |
Genetic alterations of enzalutamide and abiraterone acetate resistant prostate cancer
|
Pang, S.T.
|
|
2019
|
18 |
8 |
p. e3108
|
artikel
|
| 50 |
Genomic analysis of localised prostate cancer identifies AZIN1 as driver of metastatic progression
|
Van Den Broeck, T.
|
|
2019
|
18 |
8 |
p. e3127
|
artikel
|
| 51 |
Genomic subtypes of bladder cancer with distinct methylation profiles could be better identified by the Bladder EpiCheck test as compared to cystoscopy/urine cytology
|
Righetto, M.L.
|
|
2019
|
18 |
8 |
p. e3118
|
artikel
|
| 52 |
Human neoplastic and non-neoplastic prostate cells are sensitive to metabolic (de)regulation induced by endocrine disrupting chemicals and dietary factors
|
Vaz, C
|
|
2019
|
18 |
8 |
p. e3151
|
artikel
|
| 53 |
Hydralazine, a new hope for CRPC patients?
|
Brutt, M.
|
|
2019
|
18 |
8 |
p. e3141
|
artikel
|
| 54 |
Identification of novel long non-coding R.N.A based biomarkers in prostate cancer
|
Sattari, M.
|
|
2019
|
18 |
8 |
p. e3078
|
artikel
|
| 55 |
Immune infiltrate, immune checkpoints and mismatch repair proteins in testicular germ cell tumors: A role in prognosis and patient outcome
|
Lobo, J
|
|
2019
|
18 |
8 |
p. e3054
|
artikel
|
| 56 |
Immunogenomic analysis reveals that tumor aggressiveness is associated with a decreased CD8 T cell signature in an in vivo prostate cancer model
|
van Gelder, M.A.
|
|
2019
|
18 |
8 |
p. e3055
|
artikel
|
| 57 |
In vitro prostate tissue generation using induced pluripotent stem cells and rodent seminal vesicle mesenchyme
|
Singh, P.
|
|
2019
|
18 |
8 |
p. e3092
|
artikel
|
| 58 |
Is cold atmospheric plasma an option for bladder cancer treatment? In vitro studies
|
Guilherme, C.B.
|
|
2019
|
18 |
8 |
p. e3144
|
artikel
|
| 59 |
Level of agreement on PIRADS score assignment in a cohort of patients undergoing fusion biopsy: Comparison of original reports and internal revisions.
|
Morlacco, A.
|
|
2019
|
18 |
8 |
p. e3149
|
artikel
|
| 60 |
Macrophage-associated changes in peri-prostatic adipose tissue; a novel local driver of prostate tumorigenesis?
|
Narayanan, P.
|
|
2019
|
18 |
8 |
p. e3060
|
artikel
|
| 61 |
m6A-regulated long non-coding RNAs in prostate cancer
|
Barros-Silva, D.
|
|
2019
|
18 |
8 |
p. e3059
|
artikel
|
| 62 |
Mass spectrometry based urinary biomarkers to distinguish non-significant from significant prostate cancer
|
Frantzi, M.
|
|
2019
|
18 |
8 |
p. e3072
|
artikel
|
| 63 |
Mechanisms of ETS family transcription factors that promote prostate cancer
|
Nicholas, T.
|
|
2019
|
18 |
8 |
p. e3040
|
artikel
|
| 64 |
Metabolic and ultrastructural renal changes in adult Wistar rats fed by a cafeteria diet
|
Santos, P.F.
|
|
2019
|
18 |
8 |
p. e3064
|
artikel
|
| 65 |
Metabolic reprogramming and epigenetic landscape: an interplay to renal cell carcinoma aggressiveness promotion
|
Miranda-Gonçalves, V.
|
|
2019
|
18 |
8 |
p. e3042
|
artikel
|
| 66 |
MicroRNA-30a downregulation: Biomarker in Clear Cell Renal Cell Carcinoma
|
Outeiro-Pinho, G.
|
|
2019
|
18 |
8 |
p. e3131
|
artikel
|
| 67 |
MicroRNA-205 driven rewiring of cholesterol biosynthesis identifies therapeutic windows in aggressive prostate cancer
|
Kalogirou, C.
|
|
2019
|
18 |
8 |
p. e3089
|
artikel
|
| 68 |
MicroRNA for differentiation low and high grade of noninvasive bladder cancer
|
Borkowska, E.M.
|
|
2019
|
18 |
8 |
p. e3121
|
artikel
|
| 69 |
microRNAs regulating Tribbles-1: potential molecular targets in prostate cancer
|
Niespolo, C.
|
|
2019
|
18 |
8 |
p. e3090-e3091
|
artikel
|
| 70 |
MiR663a and VIM promoter methylation: a multiplex test for discriminating bladder cancer from inflammatory disease
|
Monteiro-Reis, S.
|
|
2019
|
18 |
8 |
p. e3085
|
artikel
|
| 71 |
Mitochondrial complex I gene mutations drive metabolic reprogramming in prostate cancer
|
Schöpf, B.
|
|
2019
|
18 |
8 |
p. e3041
|
artikel
|
| 72 |
Natural dihydrochalcones as novel AKR1C3 inhibitors in therapy-resistant prostate cancer
|
Kafka, M.
|
|
2019
|
18 |
8 |
p. e3112
|
artikel
|
| 73 |
Natural killer cells in combination with mAb cG250: a potential new therapy approach for RCC
|
Oosterwijk-Wakka, J.C.
|
|
2019
|
18 |
8 |
p. e3138
|
artikel
|
| 74 |
Organ-specific uptake of cancer-associated extracellular vesicles
|
Linxweiler, J.
|
|
2019
|
18 |
8 |
p. e3086
|
artikel
|
| 75 |
p300 and CBP targeting in castration therapy resistant prostate cancer
|
Furlan, T.
|
|
2019
|
18 |
8 |
p. e3080
|
artikel
|
| 76 |
PD-L1 expression in extracellular vesicles in renal cell carcinoma: analysis and comparison of cell lines and patient samples
|
Zeuschner, P.
|
|
2019
|
18 |
8 |
p. e3148
|
artikel
|
| 77 |
Potential urinary miRNA-141 as a biomarker for detection of prostate cancer by using screen printed carbon electrode based electrochemical microRNA sensor
|
Weng, W.H.
|
|
2019
|
18 |
8 |
p. e3123
|
artikel
|
| 78 |
Preliminary proteomic analysis of F.F.P.E. tumor samples for predicting the response of bladder cancer patients to anti-PD-1/PDL-1 therapy
|
Stroggilos, R.
|
|
2019
|
18 |
8 |
p. e3047
|
artikel
|
| 79 |
Primary cell cultures of different renal tissue species as a representative in vitro model for translational research?
|
Simon, A.
|
|
2019
|
18 |
8 |
p. e3139
|
artikel
|
| 80 |
Prognosis of bladder cancer relapse based on urinary peptides detected by mass spectrometry
|
Krochmal, M.
|
|
2019
|
18 |
8 |
p. e3074-e3075
|
artikel
|
| 81 |
Prostatic atrophy in Wistar rats’ offspring is promoted by maternal high-fat diet
|
Campos-Silva, P.
|
|
2019
|
18 |
8 |
p. e3066
|
artikel
|
| 82 |
Proteomic analysis of formalin fixed tissues for the investigation of prostate cancer
|
Mantsiou, A.
|
|
2019
|
18 |
8 |
p. e3081
|
artikel
|
| 83 |
Proteomics-driven therapeutic agents for Prostate Cancer
|
Latosinska, A.
|
|
2019
|
18 |
8 |
p. e3076
|
artikel
|
| 84 |
p300 up-regulation by docetaxel contributes to chemotherapy resistance in prostate cancer
|
Gruber, M.
|
|
2019
|
18 |
8 |
p. e3100
|
artikel
|
| 85 |
Qualitative interferon-γ release assay for predicting response to intracavitary BCG treatment in bladder cancer
|
Köseoğlu, H.
|
|
2019
|
18 |
8 |
p. e3079
|
artikel
|
| 86 |
Radiofrequency impairs viability of bladder cancer cells and has an additive effect when combined with chemotherapeutics in vitro
|
Brummelhuis, I.S.G.
|
|
2019
|
18 |
8 |
p. e3152-e3153
|
artikel
|
| 87 |
Radiologic and pathologic tumor size variation in localized renal cell carcinoma and its implications
|
Singh, S.
|
|
2019
|
18 |
8 |
p. e3114-e3115
|
artikel
|
| 88 |
Radiosensitivity of patient-derived xenograft tissue slices versus organoids in prostate cancer
|
Zhang, W.
|
|
2019
|
18 |
8 |
p. e3132
|
artikel
|
| 89 |
Radium-223 in metastatic prostate cancer: comparison of 2D and 3D cultures
|
Tavares, N.T.
|
|
2019
|
18 |
8 |
p. e3140
|
artikel
|
| 90 |
Role of toll-like receptor 3 in prostate cancer therapy-resistance
|
Muresan, X.M.
|
|
2019
|
18 |
8 |
p. e3124
|
artikel
|
| 91 |
Sealing devices on a porcine model-thermography analysis. Which device would be the gentlest with surrounding tissues, with possible implications in preserving the neurovascular bundles in laparoscopic radical prostatectomy?
|
Petrut, B.
|
|
2019
|
18 |
8 |
p. e3122
|
artikel
|
| 92 |
Simultaneous detection of the cancer biomarkers zinc and citrate in prostate cancer tissue using mass spectrometry imaging
|
Andersen, M.K.
|
|
2019
|
18 |
8 |
p. e3101-e3102
|
artikel
|
| 93 |
SLFN5 regulates amino acid metabolism by altering LAT1 expression in CRPC
|
Sánchez Martínez, R
|
|
2019
|
18 |
8 |
p. e3068
|
artikel
|
| 94 |
Stk11 and prkaca gene expressions in benign & malignant prostate diseases
|
Köseoğlu, H.
|
|
2019
|
18 |
8 |
p. e3095
|
artikel
|
| 95 |
Study on the possible interactions between FGFRL1- and AR-regulated mechanisms in prostate cancer
|
Afshan, S.
|
|
2019
|
18 |
8 |
p. e3039
|
artikel
|
| 96 |
Synthesis of steroidal oximes and epoxides and its antitumor effect against prostate cancer
|
Gomes, A.R.
|
|
2019
|
18 |
8 |
p. e3142-e3143
|
artikel
|
| 97 |
TCEAL1 loss sensitises prostate cancer cells to docetaxel treatment
|
Rushworth, L.K.
|
|
2019
|
18 |
8 |
p. e3135
|
artikel
|
| 98 |
The adipose tissue that surrounds the prostate gland exhibits traits of hypoxic state that could contribute to its role in prostate cancer progression
|
Roumiguie, M.
|
|
2019
|
18 |
8 |
p. e3043
|
artikel
|
| 99 |
The landscape of stemness-associated markers in the development of castration-resistant prostate cancer
|
Federer-Gsponer, J.R.
|
|
2019
|
18 |
8 |
p. e3128
|
artikel
|
| 100 |
The mTOR kinase directly regulates FBP1 gene expression via interaction with SWI/SNF chromatin remodeling complex in clear cell renal cell carcinoma (ccRCC).
|
Sarnowska, E.
|
|
2019
|
18 |
8 |
p. e3056
|
artikel
|
| 101 |
The radiobiological effects of Radium-223 in metastatic prostate cancer cells
|
Marques, I.
|
|
2019
|
18 |
8 |
p. e3129-e3130
|
artikel
|
| 102 |
The role of miR-378 in sarcomatoid renal cell carcinoma
|
Weng, W.H.
|
|
2019
|
18 |
8 |
p. e3073
|
artikel
|
| 103 |
The role of TET1 and hydroxymethylation in high-risk prostate cancer
|
Smeets, E.
|
|
2019
|
18 |
8 |
p. e3097
|
artikel
|
| 104 |
Transcriptomic alterations of RRM genes in clear cell renal cell carcinoma (ccRCC) as a basis for new anticancer therapy.
|
Szymanski, M.D.
|
|
2019
|
18 |
8 |
p. e3094
|
artikel
|
| 105 |
Tumor-secreted exosomal miR-424: impact on prostate tumorigenesis in mouse models and patients
|
Albino, D.
|
|
2019
|
18 |
8 |
p. e3051
|
artikel
|
| 106 |
Urothelial bladder cancer risk patterns according to tumor taxonomic subtypes
|
Benítez Dorta, R.
|
|
2019
|
18 |
8 |
p. e3053
|
artikel
|
Tijdschrift beschrijving